Navigation Links
TrialNetworks Customer to Present Results of Using Site Engagement Technology to Improve Study Operations and Patient Enrollment at Clinical Trial Optimization Conference
Date:9/27/2013

Needham, MA (PRWEB) September 27, 2013

TrialNetworks, an innovative technology company which provides the global pharmaceutical industry’s only Clinical Trial Optimization System, will sponsor and actively participate in the following prominent and collaborative events next month:

At Clinical Trial Optimization, a top-10 pharmaceutical company will present findings on using TrialNetworks technology to improve patient enrollment and trial execution in a global study. The TrialNetworks system is used by study sponsors from small biotechs to large global pharmas to optimize operations from startup through closeout – including feasibility, site activation, patient recruitment and retention, site engagement, trial conduct, online training, document management and more – all integrated within one centralized cloud-based platform.

Eric Silberstein, TrialNetworks CEO, said, “Our team is comprised of expert technologists with a deep understanding and appreciation of clinical research, and former study practitioners who are passionate about using technology to improve trial operations. We place tremendous value on sponsoring industry conferences because they provide an ideal opportunity to build strong relationships with key opinion leaders and learn about the evolving challenges our customers face.”

About TrialNetworks
TrialNetworks provides sponsors and CROs the industry's only Clinical Trial Optimization System. Using modern and intuitive technology, the TrialNetworks platform increases the quality and efficiency of clinical operations at each stage of a trial from feasibility through closeout. TrialNetworks apps, including Checklist, Document Library, Visit Guide, Action Items and Directory, are available in a unified and secure cloud-based interface. Customers ranging from Top 10 pharmaceutical companies to biotechs have implemented the TrialNetworks platform for use in Phase I-IV studies by more than 20,000 site staff in 60 countries. To learn why sponsors rely on TrialNetworks to optimize clinical trial operations, request a personalized demo at http://www.trialnetworks.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11169647.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Customer Satisfaction, A key to Success: Narang Medical Limited
2. TAKE Solutions Brings Together Leading Experts and TAKE Customers at “Converge 2012” to Discuss Business
3. Transportation and Energy Customers Look to Wharfedale’s SAP® Solutions with an Eye toward Cost Savings and Improved Operational Efficiencies
4. Sangui Bio Tech International Inc. - Over 500 Customers: Granulox Sales Ahead of Planning
5. Z Trim Holdings Grows Customer Base
6. BioInformatics LLC Announces New Market Report – Enhancing the Customer Experience: Insights and Life Science Supplier Rankings (13-002)
7. SoundConnect Announces New Not-For-Profit Customer in Smart Card Alliance
8. Rusterizer Gives Out Complimentary Rust Removers to First 100 Customers, My Cleaning Products Shares the Details
9. Puritan Medical Products Launches New Series to Tell Customer Stories
10. Veeva CRM Adds New Survey Functionality to Deepen Customer Understanding and Drive More Relevant Interactions
11. Centius – Partners with Engaged Nation– a Leading Gaming Industry Customer Loyalty Solution Provider to Help Maximize Customer Lifetime Value
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Palo Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... is set to take place on 7th and 8th June 2018 in San Francisco, ... and policy influencers as well as several distinguished CEOs, board directors and government officials ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... ... 2017 , ... For the second time in three years, ... Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, October 10th, ... mission is to change the trajectory of STEM education in America by dramatically ...
Breaking Biology Technology:
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
Breaking Biology News(10 mins):